May 30, 2018 | Harriet Kozak, Intellus, Rachel Howard, USA, emerging markets
Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia
The theme of the conference was ‘7 billion voices’, exploring how patient experiences, programs and health literacy can be improved through insights delivered by market researchers in the pharmaceutical industry.
As part of the keynote speeches, we were honored to hear the perspective of patient advocates and leaders in rare disease. Hearing directly from patients who had lived through unimaginably challenging experiences provided a humbling reminder and refocusing of our common goal as an industry – to ultimately improve patients’ lives.
Find out more:Â https://www.researchpartnership.com/news/2018/05/intellus-round-up-2018/
This content was provided by Inizio
Latest Content from Inizio
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercializationâ„¢. Now we’re back in the…
Discover how AI, analytics and real-world data are reshaping Medical Affairs.
Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.
Explore Inizio Medical’s key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.
